TNFR2 is required for RIP1-dependent cell death in human leukemia

Area of Science:

• Oncology
• Cell Death Signaling
• Molecular Biology

Background:

• Refractory/relapsed acute lymphoblastic leukemia (ALL) has a poor prognosis.
• Drug resistance in ALL is often linked to dysregulated apoptosis.
• Necroptosis offers an alternative cell death pathway for targeting high-risk malignancies.

Purpose of the Study:

• To elucidate the molecular mechanisms determining sensitivity to second mitochondria derived activator of caspase mimetics (SMs) in leukemia.
• To identify novel therapeutic targets for refractory and relapsed ALL.

Main Methods:

• Analysis of tumor necrosis factor receptor 2 (TNFR2) mRNA expression in primary human leukemia.
• Functional genetic studies using CRISPR/Cas9 to assess the roles of TNFR1 and TNFR2.
• Investigation of RIP1/TNFR1 complex formation and RIP1 phosphorylation.

Main Results:

• TNFR2 mRNA expression correlated with sensitivity to SMs in leukemia.
• TNFR1 and TNFR2, but not TNF-α, were essential for SM-induced cell death.
• TNFR2 facilitates the formation of a RIP1/TNFR1 signaling complex, inducing RIP1-dependent apoptosis and necroptosis.

Conclusions:

• TNFR1 and TNFR2 play a crucial ligand-independent role in SM-induced RIP1-dependent cell death.
• This study reveals a novel function for TNFR2 in cell death signaling.
• Identifies a potential strategy for targeting leukemias vulnerable to RIP1-dependent cell death.